Toyohiro Hirai

Also affiliated with Kyoto University Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Real-World Study of Overall Survival in Patients with Stage III Non-Small Cell Lung Cancer Treated with Chemoradiotherapy with or without Durvalumab and an Exploratory Analysis of Effective Radiation Dose to the Immune Cells”.

Real-World Study of Overall Survival in Patients with Stage III Non-Small Cell Lung Cancer Treated with Chemoradiotherapy with or without Durvalumab and an Exploratory Analysis of Effective Radiation Dose to the Immune Cells

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.713

N/A

0DataRank · unranked

0 citations

Yukinori Matsuo, Mariko Ogura, Masaki Kokubo, Norio Araki, Kota Fujii +14 more

Screening of factors inducing alveolar type 1 epithelial cells using human pluripotent stem cells

Stem Cell Reports(2024)10.1016/j.stemcr.2024.02.009

N/A

0DataRank · unranked

16 citations

Atsushi Masui, Takahiro Suezawa, Ryuta Mikawa, Toyohiro Hirai, Masatoshi Hagiwara +2 more